文献速递肝病消化道肿瘤与早癌

TACE以外的中期肿瘤治疗:从手术到系统治疗

The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy.
PubMed 文献 · J Hepatol · 2017-03-18

中期肝细胞癌(HCC)患者异质性大,经动脉化疗栓塞(TACE)可能被过度使用且并非适合所有患者。对于肿瘤负荷大、多结节播散或肝功能受损者,可考虑手术、经皮消融、放射栓塞或系统治疗作为一线;TACE失败或早期复发者应个体化管理,部分降期患者可考虑根治性手术或肝移植。本文综述BCLC B期HCC的治疗策略。

要点

  • 中期HCC异质性大,TACE可能被过度使用,并非适合所有患者。
  • 肿瘤负荷大、多结节播散或肝功能受损者,可考虑手术、消融、放射栓塞或系统治疗作为一线。
  • TACE未达完全或部分坏死及TACE后早期复发者应个体化管理,可考虑系统治疗。

核心结论

  • 中期HCC异质性大,TACE可能被过度使用且并非适合所有患者,部分患者可考虑其他治疗作为一线。

研究设计与样本

  • 综述,评估当前文献中针对巴塞罗那临床肝癌(BCLC)B期HCC患者的治疗策略。

主要发现

  • 肿瘤负荷大、多结节播散或肝功能受损的患者,TACE可能不是最优选择,可考虑手术、经皮消融、放射栓塞或系统治疗作为一线治疗。
  • 未达到完全或部分坏死(TACE失败)及TACE后早期复发的患者应个体化管理,考虑通常保留用于晚期疾病的系统治疗。
  • 在选定病例和达到降期的患者中,可考虑肝切除术甚至肝移植等根治性方法。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Treatment of hepatocellular carcinoma (HCC) is dependent on the stage of the disease. Intermediate stage HCC encompasses the largest subgroup of patients with the disease, and is characterized by substantial heterogeneity. The standard therapeutic approach, transarterial chemoembolization (TACE), is probably over-used and may not be appropriate for all patients with intermediate stage HCC. In patients with extensive tumour bulk, multi-nodular spread or impaired liver function, TACE may not be optimal and other treatments can be considered as a first-line treatment. These include surgery, percutaneous ablation, radioembolization or systemic treatment. In addition, patients who do not achieve complete or partial necrosis (TACE failure) and patients with early recurrence after TACE, should be managed individually, considering systemic treatments usually reserved for advanced disease. In selected cases and in patients who achieve downstaging, radical approaches such as hepatic resection or even liver transplantation can be considered. In this review, we evaluate the current literature for the treatment strategies for patients with intermediate Barcelona Clinic Liver Cancer (BCLC) B stage HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Galle PR, Tovoli F, Foerster F, et al. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. J Hepatol. 2017. PMID: 28323121. doi:10.1016/j.jhep.2017.03.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。